C 12 H 20 N 10 O 6 Zn, triclinic, P 1 (no. 2), a =7.231(1) Å, b =7.762(2) Å, c =8.709(2) Å, a =88.867(3)°, b =89.985(3)°, g =79.813(3)°, V =481.0 Å 3 , Z =1, R gt(F) =0.041, wRref(F 2 ) =0.105, T =296 K.
Source of material
The title complexw as synthesized under hydrothermal conditions. Amixture of Zn(CH 3 COO) 2 ·2H 2 O(0.1098 g, 0.5 mmol), 5-(4-pyridyl)-1H -tetrazole (0.0736 g, 0.5 mmol; PTZ), 0.05 ml Et 3 Nand 8mldeionized water was sealed in aTeflon-lined stainless vessel (25 ml) and heated at 423 Kfor 86 hunder autogenous pressure, then cooled slowly to room temperature.Colorless block crystalswere obtained by filtration.
Experimental details
While water Hatoms were located in aFourier differencem ap and refined with restraints, the other Hatoms were placed at calculated positions and refined using ariding model.
Discussion
Tetrazole as functional group plays an increasingly important role in coordination chemistry as ligand [1] , in medical chemistry as ametabolically stable surrogate for carboxylic acid group [2] and in various materials science applications, including special explosives [3, 4] . Inthe crystal structure of Zn(4-PTZ) 2 
